The top 100 stock
market authors
selected for publication
market authors
selected for publication
American Oriental Bioengineering Inc. (AOB)
()
- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Articles
- Instablogs
- StockTalks
- Sentiment
- Comments
- News & PR
- Market Currents
- Buzz
- Twitter: AOB
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
Analysis - Latest Articles by most recent | most commented
- How's the Economy Doing? November's 'Look Under the Hood'
- China Biotech Week in Review: CROs Consolidating
- American Oriental's Q3 Disappoints Again
- AOB's Cash Generation Provides Backstop to Earnings Miss
- American Oriental Bioengineering: Questionable Acquisitions
- AOB's Disclosures Concerning Director Cosimo Patti Appear Incomplete
- AOB Chairman's Questionable Second Passport and Potential Undisclosed Conflicts of Interest
- China Biotech Week in Review: Deals and Products
- American Oriental Adds Laryngitis Product to Portfolio
- China Biotech Takes an Important Step: FDA Approved Clinical Trials
- American Oriental Reports Approval for 61 Essential Drug List Products
- Starbucks: Highly Overvalued in a Mightily Overbought Market
- 7 'Magic Formula' Stocks of Particular Interest
- China Biotech in Review: New Cross-Border Clinical Trial
- American Oriental Reports Mixed Q2
- Closing Update for Friday, August 7: Day Up, Week Up
- Don't Dismiss American Oriental Bioengineering's Franchise Value
- Wall Street Breakfast: Must-Know News
- American Oriental Bioengineering: Undisclosed Related Party?
- China Biotech in Review: Deals, Approvals, Awards and Trials
- Questioning Berkshire Hathaway's BYD Purchase: Long-Term Economics?
- American Oriental Makes China's Top 20 Pharmas List, Aims for Top Five
- American Oriental: Established Pharma with Large, Steady Free Cash Flow
- China's Massive Healthcare Initiative Provides Vast Opportunities for Investors
- China Rising: CCG's May 18th Chinese Investment Conference
- Covered Call Strategy with American Oriental BioEngineering
- China Biotech Week in Review: Earnings
- China Sky's Reported First Quarter Earnings Raise More Questions
- American Oriental Reports Higher Revenues, Lower Profit in Q1
- Wall Street Breakfast: Must-Know News
- In the Bargain Bin: American Oriental Bioengineering
- China Biotech in Review: Cross Border Collaborations
- American Oriental Investors Remain Wary Despite Impressive Q4
- Wall Street Breakfast: Must-Know News
- China Biopharma Continues to Expand Offerings
- American Oriental Bioengineering Keeps Growing Despite Bad Moves
- Hang Seng: Full Steam Ahead
- China Biotech in Review: Earnings Week
- Why I Sold My China Positions
- American Oriental Books Another Solid Quarter
- Recessionary Equity Strategies: Having It All
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most active
Instabloggers.-
1
David Fry
-
2
TraderMark
-
3
Don Dion
-
4
Cliff Wachtel
-
5
Mike Havrilla
Top Instabloggers » -
1
-
Top StockTalkers
Top
StockTalkers.-
1
David Fry
-
2
Cliff Wachtel
-
3
Mike Havrilla
-
4
David White
-
5
Hedged In
Top StockTalkers » -
1
